We would love to hear your thoughts about our site and services, please take our survey here.
Three directors bought shares in the last placing at 1.3p. Their visibility of how the business is progressing indicates confidence going forward. Lots to look forward to.
The following directors of the Company, and therefore each a related party as defined in the AIM Rules for Companies,
participated in a subscription of new ordinary shares in the Company on 4 May 2023 (the “Subscription”):
Patrick Elliot, the Company’s Chairman, subscribed for 3,846,154 new ordinary shares in the Subscription,
which represented an amount of £50,000 at the Subscription’s issue price of 1.3 pence per new ordinary share
(the “Issue Price”).
Bruce Grey, one of the Company’s Non-Executive Directors, subscribed for 2,307,692 new ordinary shares in
the Subscription, which represented an amount of £30,000 at the Issue Price.
Anthony Kongats, the Company’s previous CEO, subscribed for 4,615,385 new ordinary shares in the
Subscription, which represented an amount of £60,000 at the Issue Price.
From Linkedin:
Feedback Medical is excited to be exhibiting at the Association of Healthcare Providers - AHPI (India) for their 11th Global Conclave 2024 on February 2-3rd. Come and visit us on stand 5 for a hands on look at our clinical communications platform Bleepa !
From RNS - 10 January 2024:
On 27 December 2023, the Delaware District Court entered judgment in favour of Maxwell Technologies in a patent infringement case asserted by CAP-XX. While CAP-XX is disappointed with the result, it is evaluating all options, including making an appeal to the Federal Circuit Court of Appeals.
Well worth a read:
https://www.rcr.ac.uk/news-policy/policy-reports-initiatives/representing-your-voice-in-uk-parliaments/cdcs-unveiled-challenges-and-triumphs/
An extract from the Report, Point 4 is basically describing Bleepa.....
Physical and digital infrastructure
Ensuring CDCs are equipped with up-to-date machines is crucial for accurate and efficient diagnostic procedures. NHSE are committed to providing new equipment for CDCs and are actively monitoring the condition of machines to maintain a high standard of care.
Digital tools, such as the iRefer tool and NHS App, are vital to streamlining diagnostics, improving efficiency and patient engagement. Unfortunately, despite pilot programmes like Feedback Medical’s digital infrastructure solutions at Queen Victoria Hospital showing significant gains, challenges with basic infrastructure and data sharing, plus inconsistent
digital advancements, persist, underscoring the need for additional funding for robust digital infrastructure.
1. NHSE should provide more centralised digital leadership by developing a national strategy for the integration of patient data and digital tools within CDCs. This strategy should outline a roadmap for the adoption of digital solutions,
including clinical decision support systems, to streamline the diagnostic process.
2. After CDC approval, system leads should conduct outreach with primary care providers within the ICS to increase awareness of the new site. If patient referrals from these providers do not reach the expected level, leads should
engage in personalised outreach. This approach addresses misconceptions, resolves hesitations, and tailors communication to improve collaboration for effective CDC integration in healthcare.
3. NHSE should prioritise bolstering digital infrastructure and patient data sharing in CDCs. Periodic assessments should be conducted to address integration challenges.
4. NHSE should develop and enforce interoperability standards for digital tools used within CDCs to ensure seamless data exchange and collaboration between primary and secondary care settings. This standardisation will enable clinicians to access patient information across different points of care, improving coordination and decision-making.
The All-Party Parliamentary Group (APPG) for Diagnostics has today, Tuesday 23 January 2024, published a review of the challenges and triumphs of community diagnostic centres (CDC) following its inquiry into their progress, including a series of roundtables in 2023.
https://bleepa.com/appg-for-diagnostics-report-reviews-community-diagnostic-centre-progress
Hi Dibs,
Bleepa is described, although not named, in the Annual Report below. Further Pathways are being developed, which suggests a strong collaboration between the Feedback Team and QVH, thus enhancing the offering to other CDCs around the country.
From the QVH 22-23 Annual Report:
QVH was an early adopter of the community diagnostic centre (CDC) model in which we deliver a number of diagnostic tests for patients referred by their general practitioner (GP). In addition, there is a digital platform through which referrals are received and the diagnostic outcome report is sent swiftly back to the patient’s GP enabling them to follow up with the patient promptly. QVH has been nationally recognised for this work particularly on the breathlessness pathway. Further clinical pathways are being developed such as for abdominal bloatedness.
I can see the additional two pilots that are currently running: "Amersham CDC in Buckinghamshire and a pan regional pilot across Buckinghamshire, Oxfordshire and Berkshire ICS (BOB ICS), looking at multiple service lines and mutual aid delivery models for sharing workforce capacity at a regional basis through the Bleepa platform." will conclude with further contracts, and if the QVH results can be replicated, will be rolled out nationally....
The All Parliamentry Party Group for Diagnostics has published a new report on community diagnostic centres today including recommendations around the development of a national strategy for the integration of patient data and digital tools.
The report included recommendations for hashtag#CDCS including the development of a national strategy for the integration of patient data and digital tools, the bolstering of digital infrastructure and patient data sharing, the development and enforcement of interoperability standards for digital tools amongst others.
“Diagnostic capacity has been expanded to bring down waiting lists in some areas and, when situated in the heart of communities, CDCs offer convenient services to those who may not typically seek healthcare. They are providing an improved patient experience and may boost staff retention for those who can rotate between CDC and acute settings,” said Maggie Throup MP, Chair of the APPG for Diagnostics.
“However, challenges persist, especially in terms of the delivery speed [..] The APPG's report serves as a roadmap for ongoing reforms and emphasises the need for sustained action to ensure the effectiveness and accountability of the CDC programme.”
Our CEO, Dr Thomas Oakley, gave evidence on our CDC programme work on symptom-based pathways with the Queen Victoria Hospital NHS Foundation Trust as part of the inquiry leading up to this report.
Dr Oakley highlighted during the inquiry that some of the barriers to scaling up our pilot with the Queen Victoria Hospital included the historical lack of digital leadership in the NHS and the need for more funding to help drive the digital infrastructure to support the CDC programme.
“Following significant investment in bricks and mortar and staffing the CDC programme is beginning to bring additional diagnostic capacity online for the NHS. Whilst this is a promising start, investment is now required for the digital infrastructure needed to connect the CDCs into the wider healthcare ecosystem. Digital is the third pillar of the build, alongside bricks and mortar and staffing: without it CDCs operate in a silo that limits their ability to impact waitlists. Results alone do not move care forwards,” said Dr Oakley.
“Results need to be presented to clinicians and rapidly turned into care decisions and this requires a digital connection that does not exist today outside of the Queen Victoria Hospital pilot. By digitally embedding CDCs into care pathways it has been shown to be possible to reduce waitlists by as much as 69% and reduce the requirement for outpatient appointments by 89%, simply by turning results into decisions. We now need to see investment in digital to supercharge the CDC programme and maximise its impact on reducing patient waitlists.”
Read the full report at the The Royal College of Radiologists here –
CDCs unveiled: challenges and triumphs | The Royal College of Radiologists (rcr.ac.uk)
From Linkedin today:
Last night Feedback Medical Ltd were awarded the Gold award 🥇 for Best Digital Solution for Rural Care by the IHW Council of India, in recognition of the work we have been doing with Bleepa connecting clinicians across care settings and bringing AI diagnostics to rural communities in the fight against TB.
We are honoured to be recognised for this groundbreaking work and want to extend our thanks to our partners Amazon Web Services (AWS) and Qure.ai
It's a setback for CPX but it's revenues should be much improved this year with the commencement of the Continental contract and improved sales and marketing by the new CEO. But back to Feedback, I would imagine that the QVH contract will be announced this week, as Feedback's contract expires on the 31st Dec., and hopefully an update from TO. But hey, I've been overly optimistic before.....!
Not a good result with Cap-xx, will undoubtedly take a heavy hit tomorrow. Seems they were outplayed by the Maxwell lawyers, but may well appeal. Well done for resisting. Sold half my holding earlier in the week so hoping that the profit I made on it will cancel out the drop tomorrow..... :o( Here's hoping for a more fruitful return from Feedback!
Hi Bill, yes, CPX is definitely an antidote to the boredom on this board... I'm optimistic of a positive result in the Maxwell/Tesla Case, hoping for a double bagger next week....;0)
From Linkedin today:
Our CEO Lars Stegmann and Director of Business Development in India Palanivelan Subramanian met with another two distributors to discuss the future of CAP-XX Limited and our partnerships.
Our first stop was at Excelpoint Systems (Pte) Ltd HQ. We were excited to have the opportunity to congratulate them in person on their recent acquisition by WT-micro.
WT-micro has become a $10 billion (USD) company since they acquired Future Electronics earlier this year so this is a promising development for Excelpoint.
We then spent time with some of the team at Serial System Ltd who are a leading distributor of electronic components and consumer products in Asia. We had the opportunity to get a glimpse into their large-scale operation which houses a team of 800 employees across 21 sales offices and 18 warehouses.
It was a pleasure to have face-to-face time with some key members of the growing CAP-XX Limited family!
Hi PR, I believe that the news flow will increase over the next few months, it is an unbelievably slow process getting established within the NHS, but once in, Bleepa/Carelocker should be there for many years. The NCA and Berkshire contracts are good examples, both have now become multiyear contracts, with Bleepa proving it's worth, illustrated in the study by Unity Insights. I'm sure it will be introduced to the remaining hospitals within the NCA very soon.
I came across this interview with Tom Oakley on Vox from a few month ago, which I had missed. Well worth watching. I get the feeling we are getting close to some new contracts.... "We are still the only platform that is commercially available that is certified as a medical device for image display"
https://videos.voxmarkets.co.uk/video/6320
Quest is one of the first outsourced reporting services to assess the benefits of enhanced communication to their service offering. Both companies believe that case-based discussion will help the outsourced reporting service to feel like a fully embedded clinical service at customer sites, enhancing the value to the customer and helping to improve the quality of the reports generated by improving Radiologist access to clinical information at the time of reporting.
Combining Bleepa's mobile-based technology with Quest's teleradiology expertise, will create a blueprint for how outsourced services should be integrated into core clinical services using the Bleepa platform and will open growth opportunities for both companies in multiple markets.
Dr Karthik Gopal, CEO of Quest, commented: "Bleepa is an extremely exciting innovation that will mean that we will be able to offer Hospitals highly efficient access to our reporting resources as well as a service to our own customers which is quicker and more efficient than ever before."
Dr Tom Oakley, CEO of Feedback, added: "This collaboration is expected to put Bleepa in the hands of more clinicians and key stakeholders and we are delighted to have been chosen to enhance Quest's product offering. Quest brings significant expertise as well as a strong network of contacts, customers and opportunities through which we aim to introduce Bleepa. We look forward to working with Quest and opening up new markets across all international territories."
Maybe be the MOU with Quest Teleradiology will come to something!
Feedback signs MOU with Quest Teleradiology to progress BleepaⓇ commercial international opportunities
Quest Teleradiology is an Indian based diagnostic and tele-reporting teleradiology service company with healthcare customers across India, the UK and Africa
· Bleepa enables image transfer from Quest customer sites to Quest Radiologists for reporting and presents the subsequent reports back to requesting clinicians
· Bleepa additionally enables two way dialogue between the referring clinician and reporting Radiologist, enhancing the clinical value of the teleradiology service
London, 11 October 2021: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical communication company, announces it has signed a Memorandum of Understanding with Quest Teleradiology Solutions ("Quest") to develop strategic opportunities for Bleepa, its flagship clinical communications platform, in the large and growing Indian healthcare market, the UK and internationally. Bleepa offers the opportunity to expand Quest's existing teleradiology service by enabling direct case discussion between requesting clinicians and reporting Radiologists alongside the traditional teleradiology reporting model.
Quest is one of India's emerging teleradiology organisations with customers across India, the UK and throughout Africa. Under the collaboration, Quest will be able to offer a more integrated reporting service to hospitals and trial Bleepa's technology with a number of its international customers to understand the added value that case discussion brings to traditional outsourced reporting models. In traditional outsourced reporting models, it is often difficult for a requesting clinician to discuss the case with the Radiologist who reports it, usually having to rely on email or switchboard coordinated calls in order to get answers to questions about the report. Similarly, it is difficult for the reporting Radiologist to get additional clinical information beyond what is contained in the imaging request, but which could enhance the quality of their report. This leads to customer dissatisfaction with many outsourced reporting services.
Yes, I'm sure all these conversations will bear fruit soon. The NHS Confederation Integrated Care Systems Network conference which Feedback attended last week for example. They have a mature product, with evidence to back up how Bleepa/Carelocker can improve efficiencies with their work at QVH and NCA.